Načítá se...
QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
BACKGROUND: Acetylcholinesterase inhibitors (AChEis) including donepezil, galantamine and rivastigmine are used to treat Alzheimer’s disease (AD). This study aimed to evaluate evidence from the case report literature for an association between these agents and risk of QT interval prolongation and To...
Uloženo v:
| Vydáno v: | Ther Adv Drug Saf |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436781/ https://ncbi.nlm.nih.gov/pubmed/32874532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098620942416 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|